China had high hopes the pandemic would launch its domestic pharmaceutical industry. That didn't happen.
After three years of COVID isolation, mainland Chinese residents are finally able to go abroad without having to quarantine when they get home. Many are using their first stops outside mainland borders to get injected with vaccines long available in much of the outside world.
Clinics in Hong Kong, which opened its borders for quarantine-free travel on Jan. 8, say they are at full capacity serving mainland tourists with mRNA booster shots produced by Germany’s BioNTech. The Hong Kong branch
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
What is so hard about making chips in America? And can the U.S. do anything about it? As part of his series, 'Remaking the Chain,' Luke Patey went searching for answers from America's past and from the last country to threaten its mantle as the world’s leading economy.
The political scientist and sinologist talks about the early days of the pandemic in Wuhan, and how the Chinese authorities’ lack of transparency led the virus to spread rapidly.
A podcast about how the two nations, once friends, are now foes.
Hear why things are so complicated now. Host Jane Perlez, former New York Times Beijing bureau chief, talks with diplomats, spies, cultural superstars like Yo Yo Ma, and more to understand why the dangers are so high, and why relations went awry.